Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Gross Profit: 2022-2025

Historic Gross Profit for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Sep 2025 value amounting to $90.5 million.

  • Arcutis Biotherapeutics' Gross Profit rose 130.65% to $90.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $286.0 million, marking a year-over-year increase of 130.22%. This contributed to the annual value of $177.4 million for FY2024, which is 224.82% up from last year.
  • Arcutis Biotherapeutics' Gross Profit amounted to $90.5 million in Q3 2025, which was up 22.32% from $74.0 million recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Gross Profit ranged from a high of $90.5 million in Q3 2025 and a low of -$2.0 million during Q2 2022.
  • Its 3-year average for Gross Profit is $40.5 million, with a median of $39.3 million in 2024.
  • Data for Arcutis Biotherapeutics' Gross Profit shows a peak YoY soared of 6,219.74% (in 2023) over the last 5 years.
  • Over the past 4 years, Arcutis Biotherapeutics' Gross Profit (Quarterly) stood at $2.5 million in 2022, then surged by 355.57% to $11.3 million in 2023, then spiked by 471.41% to $64.5 million in 2024, then soared by 130.65% to $90.5 million in 2025.
  • Its Gross Profit stands at $90.5 million for Q3 2025, versus $74.0 million for Q2 2025 and $57.0 million for Q1 2025.